NasdaqGS:PODDMedical Equipment
Insulet (PODD) Margin Compression Challenges Bullish Growth Narratives After Q1 2026 Results
Insulet (PODD) opened 2026 with Q1 revenue of US$761.7 million and basic EPS of US$1.30, while trailing twelve month revenue sat at about US$2.9 billion with basic EPS of US$4.31. This gives investors a clear view of both the quarterly print and the recent run rate. Over the last six reported quarters, revenue has moved from US$569 million in Q1 2025 to US$761.7 million in Q1 2026, with quarterly basic EPS ranging between US$0.32 and US$1.44 over that stretch. With trailing net profit margin...